Magnetic Resonance Imaging-Based Average T2 Signal as A Non-Invasive Measure of Fibrosis In Enteric Crohn's Disease

被引：0
|
作者：
Naim, I. [1 ]
Clarke, C. [2 ]
Hoad, C. [3 ]
Jinnah, N. [3 ]
Mukherjee, A. [4 ]
Gowland, P. [3 ]
Mougin, O. [3 ]
Menys, A. [1 ]
Bard, A. [1 ]
Moran, G. W. [3 ,5 ]
机构：
[1] Motilent, Res Dept, London, England
[2] Nottingham Univ Hosp NHS Trust, Dept Radiol, Nottingham, England
[3] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Nottingham, England
[4] Dept Histopathol, Nottingham, England
[5] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res, Queens Med Ctr Campus, Nottingham, England
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P013
引用
收藏
页码：I259 / I259
页数：1
相关论文
共 50 条
  • [1] MAGNETIC RESONANCE IMAGING-BASED AVERAGE T2 SIGNAL AS A NON-INVASIVE MEASURE OF FIBROSIS IN ENTERIC CROHN'S DISEASE
    Naim, Iyad
    Hoad, Caroline L.
    Clarke, Christopher
    Mukherjee, Abhik
    Jinnah, Nabeelah
    Gowland, Penny A.
    Mougin, Olivier
    Bard, Andrew
    Menys, Alex
    Moran, Gordon W.
    GASTROENTEROLOGY, 2024, 166 (05) : S608 - S609
  • [2] A non-invasive magnetic resonance imaging-based model predicts portal venous pressure
    Zhang, Qian Wen
    Wang, Yi
    Wang, Jian
    Zhao, Hong Bo
    Yu, Hong
    Liu, Shi Yuan
    Zeng, Xin
    Chen, Qi
    Hu, Zhi Qian
    Guo, Wen Yuan
    Fu, Zhi Ren
    Ding, Guo Shan
    Shi, Xue Yin
    Xie, Wei Fen
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (03) : 175 - 185
  • [3] pTRACK generated normalised average T2 signal is an accurate and sensitive measure of Perianal Crohn's disease activity
    Naim, I
    Menys, A.
    Bhatnagar, G.
    Greer, C.
    Lindsay, L.
    Carter, L.
    Moran, G.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1049 - i1049
  • [4] Evaluating the role of novel magnetic resonance imaging-based biomarkers in non-invasive assessment of hepatic fibrosis and activity in non-alcoholic fatty liver disease
    Tan, En Ying
    Chua, Sin Hui Melissa
    Tan, Eunice
    Huang, Daniel
    Lee, Jonathan
    Teng, Margaret
    Jumat, Nur Halisah Binte
    Dan, Yock Young
    Muthiah, Mark
    JOURNAL OF HEPATOLOGY, 2023, 78 : S707 - S708
  • [5] AASLD Practice Guideline on imaging-based non-invasive liver disease assessments of hepatic fibrosis and steatosis
    Sterling, Richard K.
    Duarte-Rojo, Andres
    Patel, Keyur
    Asrani, Sumeet K.
    Alsawas, Mouaz
    Dranoff, Jonathan A.
    Fiel, Maria Isabel
    Murad, M. Hassan
    Leung, Daniel H.
    Levine, Deborah
    Taddei, Tamar H.
    Taouli, Bachir
    Rockey, Don C.
    HEPATOLOGY, 2024,
  • [6] T2*Mapping to Characterize Intestinal Fibrosis in Crohn's Disease
    Huang, Si-yun
    Li, Xue-hua
    Huang, Li
    Sun, Can-hui
    Fang, Zhuang-nian
    Zhang, Meng-chen
    Lin, Jin-jiang
    Jiang, Meng-jie
    Mao, Ren
    Li, Zi-ping
    Zhang, Zhong-wei
    Feng, Shi-Ting
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (03) : 829 - 836
  • [7] Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of inadequate elastography
    Ghoz, Hassan M.
    Kroner, Paul T.
    Stancampiano, Fernando E.
    Bowman, Andrew W.
    Vishnu, Prakash
    Heckman, Michael G.
    Diehl, Nancy N.
    McLeod, Ethan
    Nikpour, Naveed
    Palmer, William C.
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2019, 9 (06) : 921 - 927
  • [8] Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease
    Maccioni, F.
    Staltari, I.
    Pino, A. R.
    Tiberti, A.
    ABDOMINAL IMAGING, 2012, 37 (06): : 944 - 957
  • [9] Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn’s disease
    F. Maccioni
    I. Staltari
    A. R. Pino
    A. Tiberti
    Abdominal Imaging, 2012, 37 : 944 - 957
  • [10] The Role of Magnetic Resonance Imaging in Detecting Intestinal Fibrosis in Crohn's Disease
    Fiorino, Gionata
    Cesarini, Monica
    Malesci, Alberto
    Danese, Silvio
    Sorrentino, Dario
    CURRENT DRUG TARGETS, 2012, 13 (10) : 1273 - 1279
12345